Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,195,261
  • Shares Outstanding, K 101,654
  • Annual Sales, $ 168,800 K
  • Annual Income, $ 67,970 K
  • 60-Month Beta 1.95
  • Price/Sales 24.72
  • Price/Cash Flow 52.97
  • Price/Book 8.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.10
  • Number of Estimates 6
  • High Estimate 0.01
  • Low Estimate -0.16
  • Prior Year 0.24
  • Growth Rate Est. (year over year) -141.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.61 +4.19%
on 02/10/20
58.00 -28.84%
on 01/15/20
-16.23 (-28.23%)
since 01/14/20
3-Month
39.61 +4.19%
on 02/10/20
73.72 -44.02%
on 11/29/19
-7.23 (-14.91%)
since 11/14/19
52-Week
17.27 +138.97%
on 03/25/19
73.72 -44.02%
on 11/29/19
+23.66 (+134.36%)
since 02/14/19

Most Recent Stories

More News
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Zuora, Arrowhead Pharmaceuticals, ResMed, and Covetrus and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Zuora, Inc. (NYSE: ZUO), Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), ResMed,...

ZUO : 15.97 (+0.63%)
ARWR : 41.27 (+0.54%)
RMD : 176.60 (+0.98%)
CVET : 12.73 (-2.60%)
Relatively Good Performance Detected in Shares of Novavax Inc in the Biotechnology Industry (NVAX , ATRA , LJPC , ESPR , ARWR)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ATRA : 14.26 (+4.47%)
LJPC : 8.40 (-1.98%)
NVAX : 7.68 (-1.41%)
ARWR : 41.27 (+0.54%)
Arrowhead Pharma Has Returned 27.7% Since SmarTrend Recommendation (ARWR)

SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 1 month, Arrowhead Pharma has returned 27.71% as of today's recent price of $42.45....

ARWR : 41.27 (+0.54%)
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

Style Box ETF report for FNY

FNY : 51.08 (+0.10%)
IWP : 162.18 (+0.42%)
MDCO : 84.90 (-0.07%)
ARWR : 41.27 (+0.54%)
CVNA : 88.62 (+1.40%)
IJK : 246.56 (+0.02%)
Arrowhead Pharma Falls 4.73% on Heavy Volume: Watch For Potential Rebound

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $40.15 to a high of $46.42. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of...

ARWR : 41.27 (+0.54%)
Arrowhead Pharmaceuticals Reports Fiscal 2020 First Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal first quarter ended December 31, 2019. The company is hosting a conference call at 4:30 p.m. EDT to discuss...

ARWR : 41.27 (+0.54%)
Arrowhead Reports Interim Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3

--- Company targets initiation of pivotal studies in 2020

ARWR : 41.27 (+0.54%)
25.3% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)

SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 3 weeks, Arrowhead Pharma has returned 25.30% as of today's recent price of $43.87....

ARWR : 41.27 (+0.54%)
Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards?

We expect Arrowhead (ARWR) to provide pipeline updates when it releases first-quarter fiscal 2020 results.

MRK : 82.65 (+0.83%)
JNJ : 150.13 (+0.03%)
GILD : 67.56 (+1.14%)
ARWR : 41.27 (+0.54%)
Arrowhead Pharma Set to Possibly Rebound After Yesterday's Selloff of 3.77%

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $42.28 to a high of $44.33. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of...

ARWR : 41.27 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 42.19
1st Resistance Point 41.73
Last Price 41.27
1st Support Level 40.65
2nd Support Level 40.03

See More

52-Week High 73.72
Fibonacci 61.8% 52.16
Fibonacci 50% 45.50
Last Price 41.27
Fibonacci 38.2% 38.83
52-Week Low 17.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar